Pamidronate comment watch save
BreastfeedingPediatric

  • TRADE NAME: Aredia (Novartis)
  • INDICATIONS: Hypercalcemia, Paget's disease, osteogenesis imperfecta
  • CLASS: Bisphosphonate
  • HALF-LIFE: 1.6 hours
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

Please login to view the rest of this drug profile.

Page last updated 08/21/2024

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top